Anticoagulation for portal vein thrombosis in cirrhosis

American Journal of Medicine

Volumn 123, Issue 9, 2010, Pages

  Qi, Xingshun ^a   Han, Guohong ^a   Wu, Kaichun ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; WARFARIN;

ANTICOAGULATION; BLEEDING; DIARRHEA; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; LIVER CIRRHOSIS; OUTCOME ASSESSMENT; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PRURITUS; RECANALIZATION; TREATMENT DURATION; TREATMENT INDICATION;

ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; FACTOR VIII; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; PORTAL VEIN; PROTEIN C; RISK FACTORS; VENOUS THROMBOSIS;

EID: 77956194800     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.03.019     Document Type: Letter

References (4)

1. S. Parikh, R. Shah, and P. Kapoor Portal vein thrombosis Am J Med 123 2010 111 119
2. K.K. Sogaard, E. Horvath-Puho, and H. Gronbaek Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study Am J Gastroenterol 104 2009 96 101
3. A. Tripodi, M. Primignani, and V. Chantarangkul An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis Gastroenterology 137 2009 2105 2111
4. C. Kearon, S.R. Kahn, and G. Agnelli Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 133 2008 454S 545S